IRIS
Armenia, Daniele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 163
NA - Nord America 31
Totale 194
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 163
US - Stati Uniti d'America 31
Totale 194
Salva come PNG Salva come JPEG
Città #
Rome 163
Santa Clara 19
Buffalo 1
Totale 183
Salva come PNG Salva come JPEG
Nome #
Comparison of Different HIV-1 Resistance Interpretation Tools for Next-Generation Sequencing in Italy 16
HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015-21 11
Bictegravir/emtricitabine/tenofovir alafenamide ensures high rates of virological suppression maintenance despite previous resistance in PLWH who optimize treatment in clinical practice 6
A high genetic heterogeneity in HBsAg can affect immunogenicity in acute hepatitis B infection 6
A recent epidemiological cluster of acute hepatitis B genotype F1b infection in a restricted geographical area of Italy 6
Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settings 6
Clinical relevance of next generation sequencing on baseline detection of minority resistance associated variants in HCV-1 patients treated with protease inhibitors 5
Emerging patterns and implications of HIV-1 integrase inhibitor resistance 5
Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings 5
A high HBsAg genetic complexity can influence HBV immunogenicity in the setting of acute infection 4
CMV seroprevalence and coronary CMV-DNA detection in immunocompetent patients with heart diseases 4
Detection of Gag C-terminal mutations among HIV-1 non-B subtypes in a subset of Cameroonian patients 4
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry 4
Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA 4
BASELINE/EARLY PRESENCE OF KNOWN AND NOVEL RESISTANCE MUTATIONS IS ASSOCIATED WITH VIRAL FAILURE IN DIFFICULT-TO-TREAT PATIENTS TREATED WITH FIRST GENERATION PROTEASE INHIBITORS 4
Darunavir (DRV)/r plus raltegravir (RAL) dual regimen in multi-experienced population: long term efficacy and tolerability 4
Temporal trend of drug-resistance and APOBEC editing in PBMC genotypic resistance tests from HIV-1 infected virologically suppressed individuals 4
HBsAg genetic elements critical for immune escape correlates with HBV reactivation upon immunosuppression 4
Virological efficacy of switch to DTG plus 3TC in a retrospective observational cohort of suppressed HIV-1 patients with or without past M184V: the LAMRES study 3
Does ultra-deep-sequencing in HCV patients treated with boceprevir/telaprevir-based therapy provide an added value in comparison to standard population-sequencing in the detection of resistance? 3
Evaluation of HIV-1 capsid genetic variability and lenacapavir (GS-6207) drug resistance-associated mutations according to viral clades among drug-naive individuals 3
P0580 : Genetic signatures specifically clustered in immune active HBsAg regions correlate with immunosuppression-driven HBV reactivation: An extensive analysis of HBV genome 3
HBcAb seropositivity is correlated with poor HIV viremia control in an Italian cohort of HIV/HBVcoinfected patients on first-line therapy 3
Anti-HIV-1 activity of new integrase inhibitors in lymphocytes and human primary macrophages 3
Genotypic Resistance Testing of HIV-1 DNA in Peripheral Blood Mononuclear Cells 3
Evaluation of Viral Suppression in Paediatric Populations: Implications for the Transition to Dolutegravir-Based Regimens in Cameroon: The CIPHER-ADOLA Study 3
Evaluation of virological response and resistance profile in HIV-1 infected patients starting a first-line integrase inhibitor-based regimen in clinical settings 3
Hepatitis B Surface Antigen Genetic Elements Critical for Immune Escape Correlate With Hepatitis B Virus Reactivation Upon Immunosuppression 3
Virological response and resistance profile in highly treatment-experienced HIV-1-infected patients switching to dolutegravir plus boosted darunavir in clinical practice 3
Impact of HIV-1 subtypes and integrase natural polymorphisms on virological response to first-line integrase inhibitors based regimens 3
A Very Low Geno2pheno False Positive Rate Is Associated with Poor Viro-Immunological Response in Drug-Naive Patients Starting a First-Line HAART 3
The Genotypic False Positive Rate Determined by V3 Population Sequencing Can Predict the Burden of HIV-1 CXCR4-using Species Detected by Pyrosequencing 3
HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia 2
P696 A COMPLEX HBV QUASISPECIES IN RT AND HBsAg CHARACTERIZES PATIENTS WITH ACUTE HEPATITIS B: A REFINED UDPS ANALYSIS 2
Identification of a rare mutation at reverse transcriptase Lys65 (K65E) in HIV-1-infected patients failing on nucleos(t)ide reverse transcriptase inhibitors 2
HIV-1 INTEGRASE MUTATIONS, FOUND AS MINORITY QUASISPECIES IN PATIENTS NAIVE TO INTEGRASE INHIBITORS, ARE ASSOCIATED WITH DECREASED SUSCEPTIBILITY TO RALTEGRAVIR AND ELVITEGRAVIR IN VITRO 2
Selection and coevolution of mutational patterns in the HIV-1 integrase characterized by pyrosequencing analysis 2
Prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and Italy 2
Viral resistance burden and APOBEC editing correlate with virological response in heavily treatment-experienced people living with multi-drug resistant HIV 2
Focus on recently developed assays for detection of resistance/sensitivity to reverse transcriptase inhibitors 2
High performance of integrase genotyping on diverse HIV-1 clades circulating in Cameroon: toward a successful transition to dolutegravir-based regimens in low and middle-income countries 2
Genotypic HIV-1 tropism determination might help to identify people with exhausted treatment options and advanced disease 2
P681 HBsAg MUTATIONS WITH ENHANCED CAPABILITY TO EVADE IMMUNE RESPONSE ARE ASSOCIATED WITH HBV REACTIVATION DURING IMMUNOSUPPRESSION 2
Impact of baseline HIV-1 integrase polymorphisms on virological outcome in a large European cohort of patients starting a raltegravir-containing regimen 2
P0915 : Clinical relevance of baseline/early detection and persistence of resistant associated variants in HCV-1 patients treated with protease-inhibitors assessed by ultra-deep sequencing 2
HCV resistance compartmentalization within tumoral and non-tumoral liver in transplanted patients with hepatocellular carcinoma 2
HIV MDR is still a relevant issue despite its dramatic drop over the years 2
Prevalence and factors associated with HIV-1 multi-drug resistance over the past two decades in the Italian ARCA database 2
Ultradeep sequencing detection of the R263K integrase inhibitor drug resistance mutation 1
The HIV-1 integrase G118R mutation confers raltegravir resistance to the CRF02_AG HIV-1 subtype 1
Poor CD4/CD8 ratio recovery in HBcAb-positive HIV patients with worse immune status is associated with significantly higher CD8 cell numbers 1
Secondary Integrase Resistance Mutations Found in HIV-1 Minority Quasispecies in Integrase Therapy-Naive Patients Have Little or No Effect on Susceptibility to Integrase Inhibitors 1
The lowest X4 Geno2Pheno false-positive rate is associated with greater CD4 depletion in HIV-1 infected patients 1
Integrase strand transfer inhibitor-based regimen is related with a limited HIV-1 V3 loop evolution in clinical practice 1
Incomplete APOBEC3G/F Neutralization by HIV-1 Vif Mutants Facilitates the Genetic Evolution from CCR5 to CXCR4 Usage 1
IMPACT OF MUTATIONS AT POSITION 135 OF HIV-1 REVERSE TRANSCRIPTASE ON VIROLOGIC RESPONSE TO A FIRST LINE NNRTI-CONTAINING HAART 1
Virological response and resistance profile in HIV-1-infected patients starting darunavir-containing regimens 1
Natural raltegravir-resistance is a rare event in integrase-inhibitors naive patients, and when present, is confined to a restricted minority of secondary variants and is not associated with virological response to raltegravir 1
Virological response and resistance in multi-experienced patients treated with raltegravir 1
Kinetics of hepatitis C virus RNA decay, quasispecies evolution and risk of virological failure during telaprevir-based triple therapy in clinical practice 1
Reliability and Clinical Relevance of the HIV-1 Drug Resistance Test in Patients With Low Viremia Levels 1
Multiple Hepatitis B Virus (HBV) Quasispecies and Immune-Escape Mutations Are Present in HBV Surface Antigen and Reverse Transcriptase of Patients With Acute Hepatitis B 1
Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimen 1
THE LOWEST X4 GENO2PHENO-FALSE POSITIVE RATE IS ASSOCIATED WITH GREATER CD4-DEPLETION 1
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen. 1
Viro-immunological response of drug-naive HIV-1-infected patients starting a first-line regimen with viraemia >500,000 copies/ml in clinical practice 1
Resistance detected in PBMCs predicts virological rebound in HIV-1 suppressed patients switching treatment. 1
Impact of pre-therapy viral load on virological response to modern first-line HAART 1
Next-generation sequencing provides an added value in determining drug resistance and viral tropism in Cameroonian HIV-1 vertically infected children. 1
Study of Genotypic and Phenotypic HIV-1 Dynamics of Integrase Mutations During Raltegravir Treatment: A Refined Analysis by Ultra-Deep 454 Pyrosequencing 1
Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro. 1
Totale 199
Salva come PNG Salva come JPEG
Categoria #
all - tutte 282
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 282
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20242 0 0 0 0 0 0 0 0 0 0 0 2
2024/2025197 55 0 12 104 17 9 0 0 0 0 0 0
Totale 199